Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase.
Argov
Z
Z
Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. zargov@md2.huji.ac.il
McKee
D
D
Agus
S
S
Brawer
S
S
Shlomowitz
N
N
Yoseph
O Ben
OB
Soreq
H
H
Sussman
J D
JD
D000110:Acetylcholinesterase / Q000378:metabolism; D000284:Administration, Oral; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000201:enzymology*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*
D002800:Cholinesterase Inhibitors; D016376:Oligonucleotides, Antisense; D000110:Acetylcholinesterase